About Chemoxy
Chemoxy is a company based in Middlesbrough (United Kingdom) founded in 1868 was acquired by Novacap in July 2017. Chemoxy has raised $30.8 million across 1 funding round from investors including NovaCap, NatWest Group and BGF. Chemoxy operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Middlesbrough, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chemoxy International Limited
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chemoxy
Chemoxy has successfully raised a total of $30.8M through 1 strategic funding round. The most recent funding activity was a Series A round of $30.8 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Chemoxy
Chemoxy has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include NovaCap, NatWest Group and BGF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Locked | Locked | Locked | |
|
NatWest Group is recognized as a UK-focused banking institution.
|
Locked | Locked | Locked | |
|
Active pharmaceutical ingredients and intermediates are developed and manufactured.
|
Locked | Locked | Locked |
Investor details for Chemoxy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chemoxy
Investment portfolio details for Chemoxy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chemoxy
Detailed financials for Chemoxy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chemoxy Comparisons
Peer comparison for Chemoxy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chemoxy
Chemoxy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Chemoxy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chemoxy
Complete news archive for Chemoxy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemoxy
Chemoxy was founded in 1868 and raised its 1st funding round 147 years after it was founded.
Chemoxy is headquartered in Middlesbrough, United Kingdom. It is registered at Middlesbrough, England, United Kingdom.
Ian Stark is the current CEO of Chemoxy.
Chemoxy is a funded company, having raised a total of $30.8M across 1 funding round to date.
Chemoxy was established in 1868 in Middlesbrough, United Kingdom, where operations in the chemical sector are centered. Contract manufacturing services for chemical intermediates are provided, supporting various industrial applications. The company is led by CEO Ian Stark, with activities focused on production processes tailored to client specifications in the European market.
Chemoxy's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
Chemoxy has 3 investors. Key investors include NovaCap, NatWest Group, and BGF.